Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Treatment of Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05832892
What this trial is testing

Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

Who this might be right for
Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Shanghai Zhongshan Hospital 41
Testing effectiveness (Phase 2)Looking for participantsNCT06584227
What this trial is testing

Adebrelimab and Chidamide for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Liu Xiufeng 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT07656376
What this trial is testing

Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation

Who this might be right for
Pancreatic CancerPancreatic Carcinoma
Jiangxi Kvvit Pharmaceutical Co., Ltd. 465
Testing effectiveness (Phase 2)Looking for participantsNCT07444541
What this trial is testing

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Anova Innovation Limited 84
Early research (Phase 1)Study completedNCT01189929
What this trial is testing

Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 57
Not applicableUnknownNCT04518800
What this trial is testing

PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer

Who this might be right for
PEG-rhG-CSFPancreatic Cancer
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07306273
What this trial is testing

IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07302841
What this trial is testing

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Tianjin Medical University Cancer Institute and Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT07101679
What this trial is testing

GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma
West China Hospital 23
Testing effectiveness (Phase 2)Ended earlyNCT01484860
What this trial is testing

Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy

Who this might be right for
Adenocarcinoma of the PancreasMetastatic Disease
University Health Network, Toronto 15
Testing effectiveness (Phase 2)UnknownNCT00024362
What this trial is testing

BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

Who this might be right for
Pancreatic Cancer
Theradex
Testing effectiveness (Phase 2)Study completedNCT03807999
What this trial is testing

Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic Neoplasm
Hacettepe University 125
Testing effectiveness (Phase 2)Ended earlyNCT01648465
What this trial is testing

Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

Who this might be right for
Gastrointestinal TumorsPancreatic TumorsGastrointestinal Neuroendocrine Tumors+1 more
Hellenic Cooperative Oncology Group 25
Testing effectiveness (Phase 2)Study completedNCT01547260
What this trial is testing

Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma MetastaticPancreatic Ductal Adenocarcinoma
Maria Liljefors 34
Post-approval studies (Phase 4)UnknownNCT02945267
What this trial is testing

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Unresectable Pancreatic Cancer
Chinese PLA General Hospital 60
Not applicableLooking for participantsNCT07326137
What this trial is testing

A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain

Who this might be right for
Advanced Biliary Tract Cancer(BTC)Advanced Pancreatic CancersCancer-related Pain
Tongji Hospital 103
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Testing effectiveness (Phase 2)Looking for participantsNCT06770452
What this trial is testing

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Carcinoma
Zhejiang University 133
Not applicableUnknownNCT04239001
What this trial is testing

Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT07595172
What this trial is testing

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Locally Advanced and Metastatic Pancreatic Cancer
West China Hospital 55
Next Page